VX14-661-108: A Phase 3, Randomized, Double-Blind, Place

  • Laguna, Terri (PI)

Project: Research project

Project Details

Description

VX14-661-108: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy and Safety of Ivacaftor and VX-661 in Combination with Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for th
StatusFinished
Effective start/end date3/20/151/1/18

Funding

  • Vertex Pharmaceuticals Incorporated

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.